Arcellx, Inc. (ACLX)

NASDAQ: ACLX · Real-Time Price · USD

72.69

+0.71 (0.99%)

Dec 11, 2025, 4:00 PM EST - Market closed

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cell Therapies	107.94M	Log In
Cell Therapies Growth	-2.16%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	107.94M	Log In
United States Growth	-2.16%	Log In